The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes
Not Applicable
- Conditions
- Type 2 Diabetes.
- Interventions
- Behavioral: The initial assessment of daily insulin dose.
- Registration Number
- NCT02143440
- Lead Sponsor
- RenJi Hospital
- Brief Summary
To investigate the daily dose of insulin in newly diagnosed Chinese type 2 diabetic patients who use the continuous subcutaneous insulin infusion (CSII) as the initial therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
All participants with type 2 diabetes, diagnosed by World Health Organization criteria, were recruited from outpatient of the Endocrinology Department in Shanghai Renji Hospital.
Exclusion Criteria
Patients who had a history of coronary heart disease, abnormal renal function, active liver disease, chronic metabolic acidosis (including diabetic ketoacidosis), or severe chronic gastrointestinal disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Newly diagnosed type 2 patients The initial assessment of daily insulin dose. The initial assessment of daily insulin dose.
- Primary Outcome Measures
Name Time Method When the glucose level decreased to about 10 mmol/L 72-96 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Renji Hospital
🇨🇳Shanghai, Shanghai, China